Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 14 May 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
地政学リスクに起因する原燃料価格の高止まりによるコスト上昇に加え、化粧品向けの微粒子製品を中心に機能性材料事業の販売が低調に推移していること等を踏まえて見直したため。
| Item | Details |
|---|---|
| Net Sales | ¥59,000 million → ¥58,000 million(-1.7%) |
| Operating profit | ¥3,300 million → ¥1,700 million(-48.5%) |
| Ordinary income | ¥3,600 million → ¥2,100 million(-41.7%) |
| Profit attributable to owners of the parent | ¥2,400 million → ¥1,300 million(-45.8%) |
| Net income per share | ¥105.18 → ¥56.09 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 May 2025 |
| Previous-period results | 売上高 55,737百万円、営業利益 3,525百万円、経常利益 3,747百万円、親会社株主に帰属する当期純利益 2,422百万円、1株あたり当期純利益 105.46円 |
| Reason for the revision | 地政学リスクに起因する原燃料価格の高止まりによるコスト上昇に加え、化粧品向けの微粒子製品を中心に機能性材料事業の販売が低調に推移していること等を踏まえて見直したため。 |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.地政学リスクに起因する原燃料価格の高止まりによるコスト上昇に加え、化粧品向けの微粒子製品を中心に機能性材料事業の販売が低調に推移していることなどを踏まえたため。